HEPARIN for Coronary arterial stent insertion: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where HEPARIN was used for Coronary arterial stent insertion.
Most Reported Side Effects for HEPARIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 2,294 | 12.6% | 346 | 1,024 |
| Heparin-induced thrombocytopenia | 2,057 | 11.3% | 366 | 1,127 |
| Off label use | 1,077 | 5.9% | 334 | 542 |
| Thrombocytopenia | 781 | 4.3% | 106 | 418 |
| Haemorrhage | 684 | 3.8% | 157 | 328 |
| Pulmonary embolism | 652 | 3.6% | 254 | 440 |
| Drug hypersensitivity | 629 | 3.5% | 117 | 179 |
| Thrombosis | 603 | 3.3% | 200 | 299 |
| Foetal exposure during pregnancy | 582 | 3.2% | 58 | 107 |
| Anaemia | 576 | 3.2% | 188 | 431 |
| Maternal exposure during pregnancy | 561 | 3.1% | 16 | 170 |
| Condition aggravated | 552 | 3.0% | 252 | 365 |
| Multiple organ dysfunction syndrome | 476 | 2.6% | 441 | 239 |
| Gastrointestinal haemorrhage | 454 | 2.5% | 127 | 291 |
| Premature baby | 452 | 2.5% | 40 | 84 |
Other Indications for HEPARIN
Product used for unknown indication (3,746)
Anticoagulant therapy (3,476)
Thrombosis prophylaxis (1,633)
Pulmonary embolism (786)
Deep vein thrombosis (603)
Atrial fibrillation (467)
Prophylaxis (464)
Thrombosis (378)
Acute myocardial infarction (294)
Foetal exposure during pregnancy (179)
Other Drugs Used for Coronary arterial stent insertion
CLOPIDOGREL BISULFATE (760)
ASPIRIN (376)
TICAGRELOR (206)
PRASUGREL (108)
RIVAROXABAN (91)
CLOPIDOGREL (33)
APIXABAN (32)
PLAVIX (31)
ATORVASTATIN (28)
ASPIRIN DL-LYSINE (24)